+6,611.3%
AXON vs CHTR
+295.4%
+6,315.9%
-65.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | CHTR | Excess | Alpha |
|---|---|---|---|---|
| 1D | +2.7% | +4.3% | -1.6% | +1.5% |
| 7D | +0.8% | +17.2% | -16.4% | -3.7% |
| 30D | -22.8% | +31.6% | -54.4% | -28.5% |
| 3M | -48.8% | -11.6% | -37.2% | -47.5% |
| 6M | -16.3% | -3.3% | -13.0% | -16.9% |
| YTD | -44.5% | -33.7% | -10.8% | -40.8% |
| 1Y | -43.4% | -32.4% | -11.0% | -40.0% |
| 3Y | +44.3% | -65.9% | +110.2% | +79.4% |
| 5Y | +85.1% | -79.9% | +165.0% | +170.5% |
| 10Y | +1,060.5% | -49.2% | +1,109.7% | +1,090.7% |
| All | +6,611.3% | +295.4% | +6,315.9% | +3,672.1% |
Cumulative growth
Daily Returns
Daily percentage return beside CHTR.
Daily Out/Under-Performance
Portfolio return minus CHTR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CHTR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded CHTR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling